If you have severe diarrhea and flushing associated with carcinoid syndrome, you are not alone. RealSupport™ is here with information and tools to help you understand your condition and get the most out of your treatment experience.
Warnings and Precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, with postmarketing reports of gallstones resulting in complications (inflammation of the gallbladder, bi...
See MoreSandostatin® LAR Depot (octreotide acetate) for injectable suspension is indicated for patients in whom initial treatment with immediate-release Sandostatin® (octreotide acetate) Injection has been shown to be effective and tolerated for
Sandostatin LAR Depot works by blocking the production of a number of hormones that can lead to severe diarrhea and flushing associated with carcinoid syndrome. Your doctor will identify if Sandostatin LAR Depot is right for you based on your response to, and how well you tolerate, 2 weeks of treatment with Sandostatin® (octreotide acetate) Immediate-Release Injection.
Are you currently taking Sandostatin® LAR Depot (octreotide acetate) for injectable suspension? You may be eligible to have your monthly injection given at home by a trained health care professional.
Use of website is governed by the Terms of Use and Privacy Policy.
Copyright © 2022 Novartis Pharmaceuticals Corporation. All rights reserved.
You are now leaving the Novartis site and moving to an external website independently operated and not managed by Novartis Pharmaceuticals Corporation. Novartis assumes no responsibility for the site. If you do not wish to leave this site, click Cancel. Or click OK to continue.
